Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mary E. Schramm"'
Publikováno v:
The Service Industries Journal. :1-21
Despite the interest in encouraging patients to participate in their care, knowledge of the relationship between patients’ characteristics and the extent to which they want to participate in their ...
Publikováno v:
Journal of Communication Management.
PurposeBetween 1985 and 2000, the six largest US pharmaceutical firms entered a very active period of partnerships with other pharmaceutical firms to expand their knowledge of biotechnology-based research and development (R&D) frameworks and to bolst
Autor:
Mary E. Schramm, Abhik Roy
Publikováno v:
Journal of Advertising Research. 60:305-323
The oligopolistic nature of the U.S. pharmaceutical industry presents its members with a unique opportunity to leverage the interaction between competitive pricing strategy and promotion strategy. Previous studies have examined the role of direct-to-
Publikováno v:
The Service Industries Journal. 39:1167-1189
This research improves understanding of how consumers integrate their evaluations of ethical attributes with other service features in making brand choices. Although consumers appreciate brands the...
Publikováno v:
Pharmaceutical Medicine. 31:309-315
A heated debate surrounds pharmaceutical companies’ proactive dissemination of information about uses of their drugs beyond those approved by the US Food and Drug Administration (FDA), a practice commonly referred to as “off-label promotion”. A
Autor:
Mary E. Schramm, Erika L. Paulson
Publikováno v:
Journal of Historical Research in Marketing. 9:41-65
Purpose This paper aims to explore how home economists, employed by the Good Housekeeping Institute, may have influenced the use of principles from the home economics movement in advertising appeals for electric appliances. Design/methodology/approac
Publikováno v:
Journal of Product Innovation Management. 33:549-569
Traditionally, firms in the pharmaceutical industry have depended on their internal research and development (R&D) capabilities to maintain a productive new product pipeline. During the past two decades, however, the industry's pipeline productivity
Publikováno v:
International Journal of Pharmaceutical and Healthcare Marketing. 8:295-313
Purpose– The purpose of the study is to review The False Claims Act (FCA) settlements and challenges facing the industry to suggest the motivation behind firms’ alleged fraudulent activity. FCA has been applied against pharmaceutical companies by
Autor:
Mary E. Schramm, Michael Y. Hu
Publikováno v:
Journal of Product Innovation Management. 30:203-213
During the past three decades, a series of changes in the market environment have altered the structure of the pharmaceutical industry. While these changes have benefitted the generic drug sector, the effect on the branded drug sector has been detrim
Publikováno v:
Decision Support Systems. 50:234-242
Market members interact within a complex, adaptive system to effect adoption decisions and the resulting diffusion of innovations. Agent-based modeling (ABM) is a methodology well suited for simulating this system. It complements and extends economet